New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2012
07:12 EDTVICLVical coverage assumed with an Outperform at Credit Suisse
Target $5.
News For VICL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 8, 2014
06:33 EDTVICLVical granted six U.S. patents for HSV-2 vaccines
Vical has been issued six U.S. patents that provide broad coverage of DNA vaccines for herpes simplex virus type 2, containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant. The intellectual property is jointly owned by the University of Washington and Vical.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use